Skip to Content
Find More Like This
Return to Search

Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface

United States Patent

December 12, 2006
View the Complete Patent at the US Patent & Trademark Office
The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
Meagher; Richard B. (Athens, GA), Laterza; Vince (Decatur, GA)
University of Georgia Research Foundation, Inc. (Athens, GA), Abeome Corporation (Athens, GA)
10/ 079,130
February 20, 2002
ACKNOWLEDGMENTS This invention was made with government support under the National Institutes of Health (Grant GM36397) and the Department of Energy (Grant DE-FG07-96ER20257). The U.S. Government may have certain rights in this invention.